|Day Low/High||13.84 / 13.98|
|52 Wk Low/High||11.00 / 20.85|
Germany's Fresenius SE said a probe into alleged data breaches at Akorn could scupper its planned $5 billion takeover of the Lake Forest, Ill.-based generic drugmaker.
Global stocks were mixed in early Tuesday trading as investors sifted through prepared remarks ahead of the first of two appearances on Capitol Hill this week by new Fed chairman Jerome Powell.
Fresenius announced a deal to buy U.S. generic drugmaker Akorn Inc for $4.75 billion, or $34 per share.
European stocks extended gains Tuesday as global markets continued to rally in the wake of Emmanuel Macron's victory in Sunday's presidential elections in France and improving corporate earnings.
Fresenius announced a deal to buy U.S. generic drugmaker Akorn Inc for $4.75 billion and the biosimilars unit of German peer Merck KGaA.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.